About Us | SpectraWAVE, Inc.

Founders

Founded in 2017 by a group of leading clinicians, technologists and medical device entrepreneurs, SpectraWAVE is driven to improve coronary artery disease outcomes with photonics

Gregg Stone, MD, FACC, MSCAI

Gregg Stone, MD, FACC, MSCAI

Professor of Medicine,
Mount Sinai Heart Health System

Guillermo Tearney, MD, PhD

Guillermo Tearney, MD, PhD

Professor of Pathology, Massachusetts General Hospital

James Muller, MD

James Muller, MD

Cardiologist
Brigham and Women's Hospital

Jeffrey O'Donnell

Jeffrey O'Donnell

CEO
Trice Medical

Board of Directors

Bill Little

Bill Little

Chief Operating Officer
Neovasc

Chuck Simonton, MD

Chuck Simonton, MD

VP and CMO
Abiomed

Eman Namati, PhD

Eman Namati, PhD

CEO
SpectraWAVE

Eric Swanson

Eric Swanson

Independent

Guillermo Tearney, MD, PhD

Guillermo Tearney, MD, PhD

Professor of Pathology, Massachusetts General Hospital

Steve Weinstein

Steve Weinstein

Independent

Bill Little

Bill Little

Chief Operating Officer
Neovasc

Chuck Simonton, MD

Chuck Simonton, MD

VP and CMO
Abiomed

Eman Namati, PhD

Eman Namati, PhD

CEO
SpectraWAVE

Eric Swanson

Eric Swanson

Independent

News

SpectraWAVE Expands Company Leadership, Appointing Two New Vice Presidents to Executive Team

SpectraWAVE Announces $13.2 Million Series A-2 Financing from Existing Investors to Bring Intracoronary Imaging Technology to Market

SpectraWAVE Appoints Eman Namati, Ph.D., as Chief Executive Officer to Lead Development and Launch of Flagship Technology